Spots Global Cancer Trial Database for idhr132 mutations
Every month we try and update this database with for idhr132 mutations cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations | NCT02381886 | Advanced Malign... | IDH305 | 18 Years - | Novartis | |
| A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations | NCT02381886 | Advanced Malign... | IDH305 | 18 Years - | Novartis | |
| Trial of IDH305 in IDH1 Mutant Grade II or III Glioma | NCT02977689 | Glioma | IDH305 | 18 Years - | NYU Langone Health | |
| Trial of IDH305 in IDH1 Mutant Grade II or III Glioma | NCT02977689 | Glioma | IDH305 | 18 Years - | NYU Langone Health |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
